TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.6600
-0.0310 (-4.49%)
Jul 27, 2026, 10:26 AM EDT - Market open
TELA Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -39.84 | -38.83 | -37.84 | -46.66 | -44.3 | -33.28 |
Depreciation & Amortization | 1.01 | 1.01 | 1.01 | 0.81 | 1.19 | 0.54 |
Stock-Based Compensation | 3.57 | 3.8 | 4.36 | 5.03 | 3.99 | 3.66 |
Other Adjustments | 3.89 | 4.39 | -4.29 | 1.64 | 4.14 | 2.12 |
Change in Receivables | 0.89 | -0.11 | -0.76 | -3.06 | -2.42 | -1.55 |
Changes in Inventories | -1.32 | -0.5 | -2.97 | -2.72 | -6.07 | -5.19 |
Changes in Accounts Payable | -0.12 | 0.14 | 0.48 | 0.01 | -0.88 | 1.4 |
Changes in Accrued Expenses | 1.19 | 1.76 | -1.81 | 4.18 | 2.4 | 2.67 |
Changes in Other Operating Activities | 0.18 | 0.13 | 0.23 | -0.08 | 1.22 | -0.99 |
Operating Cash Flow | -29.66 | -28.22 | -41.6 | -40.86 | -40.75 | -30.43 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.54 | -0.45 | -0.99 | -0.61 | -0.87 | -0.63 |
Sale of Property, Plant & Equipment | - | - | - | 0.01 | - | - |
Purchases of Intangible Assets | - | - | - | - | -1 | - |
Proceeds from Business Divestments | 1.43 | 1.29 | 5.44 | - | - | - |
Investing Cash Flow | 0.9 | 0.85 | 4.45 | -0.6 | -1.87 | -0.63 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 60 | - | - | 40 | - |
Long-Term Debt Repaid | - | -42.42 | - | - | -30 | - |
Net Long-Term Debt Issued (Repaid) | - | 17.58 | - | - | 10 | - |
Issuance of Common Stock | 0.07 | 11.93 | 43.43 | 46.56 | 34.47 | 0.59 |
Repurchase of Common Stock | -0.11 | -0.21 | -0.37 | -0.29 | -0.16 | - |
Net Common Stock Issued (Repurchased) | -0.04 | 11.72 | 43.06 | 46.27 | 34.31 | 0.59 |
Other Financing Activities | -0.25 | -3.55 | - | - | -3.46 | - |
Financing Cash Flow | 25.57 | 25.75 | 43.06 | 46.27 | 40.85 | 0.59 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.11 | -0.22 | 0.03 | 0.16 | -0.14 | 0.01 |
Net Cash Flow | -3.31 | -1.84 | 5.94 | 4.98 | -1.91 | -30.46 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -30.2 | -28.67 | -42.58 | -41.47 | -41.62 | -31.06 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -37.37% | -35.71% | -61.45% | -70.94% | -100.49% | -105.42% |
Free Cash Flow Per Share | -0.60 | -0.61 | -1.49 | -1.81 | -2.56 | -2.15 |
Levered Free Cash Flow | -39.43 | -19.16 | -41.89 | -45.08 | -37.32 | -35.48 |
Unlevered Free Cash Flow | -33.6 | -31.86 | -38.03 | -42.49 | -42.03 | -31.66 |